Clinical Trial Detail

NCT ID NCT01926587
Title Oral Rigosertib in Combination With Azacitidine
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Onconova Therapeutics, Inc.
Indications

bone marrow cancer

acute myeloid leukemia

chronic myeloid leukemia

Therapies

Azacitidine + Regorafenib

Age Groups: adult

No variant requirements are available.